Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radioimmunoscintigraphy of orbital metastases from ovarian carcinoma

Journal Article · · Clinical Nuclear Medicine; (USA)

Radioimmunoscintigraphy with I-123 labeled monoclonal antibody HMFG1 has been used for imaging primary and metastatic ovarian neoplasms. Uptake of I-123 labeled HMFG1 is reported in a patient with an orbital metastasis from a primary ovarian adenocarcinoma. Radioimmunoscintigraphy may have a role to play in imaging metastatic orbital neoplasms.

OSTI ID:
5960445
Journal Information:
Clinical Nuclear Medicine; (USA), Journal Name: Clinical Nuclear Medicine; (USA) Vol. 15:11; ISSN CNMED; ISSN 0363-9762
Country of Publication:
United States
Language:
English